Alphyn Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$25M
- Investors
-
5
Alphyn General Information
Description
Developer of therapeutics for severe and prevalent skin diseases designed for multiple bioactive therapeutic drugs. The company's lead candidate for atopic dermatitis (AD) treats the bacterial cause and exacerbation of the disease, in addition to directly treating itch, inflammation, and infection that make AD so difficult to manage; it is also advancing a candidate for epidermolysis bullosa, enabling patients with a safe and effective cure for bacterial skin infections.
Contact Information
Website
www.alphynbiologics.comCorporate Office
- 3724 Thomas Point Road
- Annapolis, MD 21403
- United States
Corporate Office
- 3724 Thomas Point Road
- Annapolis, MD 21403
- United States
Alphyn Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 12-Dec-2025 | $25M | Completed | Clinical Trials - Phase 2 | ||
| 3. Early Stage VC (Series A) | 20-May-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 30-Jun-2021 | $2.48M | $3.68M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 31-Mar-2020 | $1.2M | $1.2M | Completed | Startup |
Alphyn Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 5,500,000 | $0.000100 | 8% | $0.45 | $0.45 | 1x | $0.45 | 12.7% |
| Series A-1 | 3,200,000 | $0.000100 | 8% | $0.39 | $0.39 | 1x | $0.39 | 7.39% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Alphyn Comparisons
Industry
Financing
Details
Alphyn Competitors (3)
One of Alphyn’s 3 competitors is Incyte, a Formerly VC-backed company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Incyte | Formerly VC-backed | Wilmington, DE | ||||
| Arcutis Biotherapeutics | Formerly VC-backed | Westlake Village, CA | ||||
| Dermavant Sciences | Formerly PE-Backed | Long Beach, CA |
Alphyn Patents
Alphyn Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022226676-A1 | Composition for treatment of topical dermatological bacterial skin conditions | Pending | 25-Feb-2021 | ||
| CA-3209718-A1 | Composition for treatment of topical dermatological bacterial skin conditions | Pending | 25-Feb-2021 | ||
| EP-4297765-A1 | Composition for treatment of topical dermatological bacterial skin conditions | Pending | 25-Feb-2021 | ||
| EP-4297765-A4 | Composition for treatment of topical dermatological bacterial skin conditions | Pending | 25-Feb-2021 | ||
| US-12150970-B2 | Composition for treatment of topical dermatological bacterial skin conditions | Active | 25-Feb-2021 | A61K36/47 |
Alphyn Signals
Alphyn Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel Star Ventures | Angel Group | Minority | ||
| Opus8 | PE/Buyout | Minority | ||
| Angel Physicians Fund | Angel Group | Minority | ||
| Queen City Angels | Angel Group | Minority | ||
| Serial Stage Venture Partners | Venture Capital | Minority |
Alphyn FAQs
-
When was Alphyn founded?
Alphyn was founded in 2019.
-
Where is Alphyn headquartered?
Alphyn is headquartered in Annapolis, MD.
-
What is the size of Alphyn?
Alphyn has 4 total employees.
-
What industry is Alphyn in?
Alphyn’s primary industry is Drug Discovery.
-
Is Alphyn a private or public company?
Alphyn is a Private company.
-
What is the current valuation of Alphyn?
The current valuation of Alphyn is .
-
What is Alphyn’s current revenue?
The current revenue for Alphyn is .
-
How much funding has Alphyn raised over time?
Alphyn has raised $34M.
-
Who are Alphyn’s investors?
Angel Star Ventures, Opus8, Angel Physicians Fund, Queen City Angels, and Serial Stage Venture Partners have invested in Alphyn.
-
Who are Alphyn’s competitors?
Incyte, Arcutis Biotherapeutics, and Dermavant Sciences are competitors of Alphyn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process